Dan Ferariu

Institutul Regional de Oncologie

Papers

1

Total Citations

25

H-Index

1

About

Driven by a deep curiosity about how cancer evades treatment, Dan Ferariu has carved a niche at the intersection of tumor microenvironment dynamics and drug resistance. His research centers on the epigenetic mechanisms that allow cancer cells to survive therapy, with a particular focus on how the surrounding microenvironment—rather than random mutation—can trigger non-sporadic, coordinated shifts in protein expression. In his most cited work (2018, 25 citations), Ferariu provided compelling evidence that specific microenvironments impose the expression of AXL and cKIT receptors, linking these changes directly to epithelial plasticity and the acquisition of drug tolerance. This finding challenges the dominant "rare cell" theory of resistance, suggesting instead that the tumor's own ecosystem can actively instruct cells to become resilient. By illuminating this microenvironment-driven pathway, Ferariu’s contributions offer a new framework for understanding therapy failure and point toward novel strategies for disrupting resistance before it takes hold. His work stands as a vital resource for students and researchers seeking to unravel the complex dialogue between cancer cells and their surroundings.

Research Focus

Key Achievements

1
H-Index
1
Papers
25
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
Microenvironment-Induced Non-sporadic Expression of the AXL and cKIT Receptors Are Related to Epithelial Plasticity and Drug Resistance
25 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Institutul Regional de Oncologie

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago